Sildalis
In brief
- In many online pharmacies and unofficial suppliers you can buy sildalis without a prescription or receipt; however, in regulated jurisdictions sildenafil and tadalafil are prescription-only and Sildalis is not registered with major agencies.
- Sildalis is used for erectile dysfunction; it combines two PDE5 inhibitors — sildenafil and tadalafil — which increase cGMP in penile smooth muscle to promote vasodilation and erection.
- The usual dose is one tablet containing 100 mg sildenafil + 20 mg tadalafil, taken about 30–60 minutes before anticipated sexual activity and not more than once in 24 hours.
- The form of administration is an oral tablet (typically red, oval tablets in blister packs).
- The onset of effect is usually 30–60 minutes (sildenafil commonly 30–60 minutes; tadalafil can onset within 30 minutes in some users).
- Duration of action varies: the sildenafil component typically lasts around 4–6 hours, while the tadalafil component can persist up to 36 hours, so combined effects may include short-term and prolonged activity.
- Alcohol warning: avoid heavy alcohol consumption as it can increase dizziness, lower blood pressure and reduce effectiveness; do not combine with nitrates or riociguat due to risk of life‑threatening hypotension.
- The most common side effect is headache.
- Would you like to try “sildalis” without a prescription?
Critical Warnings, Restrictions And Patient Protection (Australia)
Basic Sildalis Information
- INN (International Nonproprietary Name): Sildalis does not have an official INN and is a combination product containing sildenafil citrate (INN: sildenafil) and tadalafil (INN: tadalafil).
- Brand Names Available In Australia: Sildalis is marketed mainly through internet sellers rather than registered Australian pharmacies and typically appears as red, oval tablets in blister packs labelled in English or Russian.
- ATC Code: Sildenafil corresponds to G04BE03 and tadalafil corresponds to G04BE08 in the ATC classification.
- Forms & Dosages: Sold as tablets that typically contain 100 mg sildenafil plus 20 mg tadalafil in blister packs of 6–20 tablets.
- Manufacturers In Australia: Sildalis is not manufactured by major originators in Australia and is generally produced by overseas generic manufacturers, often Indian companies or direct‑to‑web suppliers.
- Registration Status In Australia: There is no public record of Sildalis registered as a fixed sildenafil/tadalafil combination with major regulators or as an ARTG entry as a combination product.
- OTC / Rx Classification: Sildenafil and tadalafil are prescription medicines where regulated, and Sildalis is considered prescription‑only in those jurisdictions though sold without prescription by some online shops.
Start here for safety: Sildalis is a non‑standard combination of sildenafil and tadalafil that is sold mainly online and is not registered as a combination product in public regulatory listings.
Prioritise an initial screening and documentation before any supply because formal pharmacokinetic and combination safety data are not established for this fixed product.
Absolute contraindications include concomitant use with nitrates such as nitroglycerin and with riociguat because of the risk of life‑threatening hypotension.
Treat patients with recent myocardial infarction, unstable angina, uncontrolled arrhythmia or other significant cardiovascular disease as high risk and do not supply without cardiology clearance.
- Initial Screening Checklist: Current medications, cardiovascular history, nitrate use, recent stroke or myocardial infarction, vision problems, liver or kidney disease, and allergy history.
Emergency Signs Requiring ED:
- Priapism lasting more than 4 hours.
- Severe chest pain or suspected myocardial infarction.
- Syncope or new onset severe hypotension.
- Sudden, severe visual loss or persistent visual disturbance.
High-Risk Groups
- Elderly
- Start at a lower dose for older patients and monitor blood pressure and cardiovascular tolerance because of higher risk of hypotension and adverse events.
- Pregnancy And Children
- Sildalis is intended for men with erectile dysfunction and is not indicated in pregnancy or children.
- Chronic Illness
- Patients with liver or kidney impairment, uncontrolled diabetes, or unstable cardiovascular disease require dose adjustment or avoidance and specialist review.
Counsel elderly patients about dizziness and fall risk and document the agreed plan.
Interaction With Activities
Advise caution with driving or operating heavy machinery if dizziness, visual disturbance or syncope occurs after taking any PDE5 inhibitor.
A patient starting a new product should avoid driving until they know how they tolerate it.
Discuss workplace safety and document that advice as part of the counselling record.
Can I Drive After Taking It In Australia?
Avoid driving if you feel dizzy, faint, or experience visual changes after taking the medication.
If the dose has been tolerated previously without side effects, driving is generally permitted, but record the counselling in the patient notes.
- Patient Counselling Checklist: Confirm absence of dizziness or visual symptoms, advise not to drive on first dose or if dose changed, document advice, and provide written action steps if symptoms appear.
Usage Basics: INN, Brand Names And Legal Status In Australia
Sildalis does not have an official INN because it is a fixed combination of two recognised INNs, sildenafil and tadalafil.
Both sildenafil and tadalafil are well established agents for erectile dysfunction and are listed under their respective INNs.
Most Sildalis products sold online are red, oval tablets packaged in blisters and often labelled in English or Russian, rather than via Australian wholesalers.
INN And Brand Names Available In Australia
- Licensed single agents available in Australia include Viagra® (sildenafil) and Cialis® (tadalafil).
- Sildalis is an unregistered combination product typically supplied by online or overseas sellers and is not a licensed Australian pharmaceutical brand.
- Comparison: Licensed single agents offer TGA registration, established dosing, and known safety profiles, whereas Sildalis lacks regulatory approval and robust combination PK data.
Choose licensed products when possible because they have clearer clinical and subsidy pathways.
Legal Classification
| Product | TGA Registration | PBS Subsidy |
|---|---|---|
| Viagra® (sildenafil) | Registered | Depends On Formulation And Indication |
| Cialis® (tadalafil) | Registered | Depends On Formulation And Indication |
| Sildalis (sildenafil + tadalafil) | Not Registered As A Combination | Not PBS‑Listed |
Both sildenafil and tadalafil remain prescription medicines in Australia and Sildalis as a fixed combo is not PBS‑listed.
Dosing Guide And Regimen Advice
Typical online Sildalis packs contain 100 mg sildenafil plus 20 mg tadalafil per tablet and the usual instruction is one tablet 30–60 minutes before sexual activity, not more than once per 24 hours.
That combination effectively delivers two full‑dose PDE5 inhibitors in a single pill and increases the chance of additive adverse effects like hypotension, headache and visual changes.
Standard Regimens
Clinical practice and PBS recommendations use single agents with established regimens, for example sildenafil in several strengths and tadalafil as 2.5–20 mg either daily or as needed.
There is no established dosing guidance for routine combination therapy of sildenafil plus tadalafil and Sildalis should be treated with extreme caution if encountered.
Adjustments For Comorbidities
Lower starting doses are advised for elderly patients and those with moderate to severe hepatic or renal impairment because clearance of either agent may be reduced.
Avoid use in children as safety and efficacy have not been established.
What If I Miss A Dose?
Not applicable for Sildalis because it is taken as needed before sexual activity.
If a dose is missed, take only before the next planned activity and do not double the dose or take more than one tablet in 24 hours.
- Overdose Emergency Checklist: Seek emergency care for priapism, severe hypotension, syncope or seizures.
- Dosing Counselling Points: Max once per 24 hours, take 30–60 minutes before activity, avoid nitrates, moderate alcohol intake, and review other medicines with a pharmacist.
Interaction Chart — Food, Drink And Common Drug Conflicts
Major interactions with Sildalis reflect the known interactions for sildenafil and tadalafil individually and include several high‑risk combinations.
| Drug/Food | Interaction Severity | Clinical Action |
|---|---|---|
| Nitrates (eg nitroglycerin) | Absolute Contraindication | Do Not Co‑prescribe or Supply; Seek Immediate Advice If Taken Together |
| Riociguat | Absolute Contraindication | Do Not Use Concomitantly |
| Alpha‑Blockers | Major (Additive Hypotension) | Start Low, Dose Separately, Monitor Blood Pressure |
| Potent CYP3A4 Inhibitors (eg ritonavir) | Major (Increased PDE5 Levels) | Consider Dose Reduction Or Avoid Combination; Review With Prescriber |
| Grapefruit Juice | Moderate | Avoid Large Amounts; May Alter Metabolism |
Food And Drinks
Alcohol can increase orthostatic hypotension risk and may worsen erectile function; advise moderation when taking any PDE5 inhibitor.
High‑fat meals delay absorption of sildenafil and can make onset slower, while tadalafil is less affected by food.
Common Drug Conflicts
- Nitrates and riociguat are absolute contraindications.
- Protease inhibitors and other potent CYP3A4 inhibitors can markedly increase sildenafil or tadalafil exposure.
- Some antibiotics and antifungals interacting with CYP3A4 should trigger pharmacist review prior to supply.
Use a medication reconciliation and a drug‑interaction checker before recommending or supplying any PDE5 product.
User Reports, Trends And Safety Signals (Australian Context)
Sildalis appears commonly in online searches as an “enhanced potency” product, but consumer reports are anecdotal and the product lacks formal regulatory evaluation.
Online reviews and forum anecdotes may claim stronger effect but also report more frequent headaches, back pain and variability in tablet appearance.
- Common User Themes: Perceived stronger effect, mixed tolerability, inconsistent tablet appearance, and price sensitivity.
Warn patients that internet reviews are subject to bias and counterfeit risk and that batch traceability is often absent with unofficial suppliers.
- What To Ask Patients Reporting Harms: Dose taken, source or supplier, co‑medications, duration of use and specific side effects experienced.
Encourage reporting adverse events to the TGA and advise patients to keep packaging photos and lot numbers if possible.
For rural patients, recommend contacting the local pharmacist first and emergency services for priapism or fainting episodes.
Access And Purchase Options In Australia (Legal And Practical)
Legitimate access to sildenafil and tadalafil requires a prescription from a GP or via a telehealth consult and is dispensed through community pharmacies and accredited online Australian pharmacies.
Sildalis branded combination packs are primarily supplied by international or unofficial online sellers and often arrive without Australian quality assurance.
In our online pharmacy, sildalis is available without a prescription, with discreet delivery to Australia in 9-21 days.
National Chains
- Chemist Warehouse, Priceline and TerryWhite Chemmart provide in‑store pharmacist counselling and can fill private prescriptions.
- These chains may offer generic sildenafil at competitive prices and will advise on PBS eligibility where applicable.
Online Pharmacies And Telehealth E‑Prescriptions
- Use telehealth for legitimate e‑prescriptions and choose accredited Australian online pharmacies rather than overseas suppliers.
- Verification Checklist: AHPRA‑registered prescriber, pharmacy accreditation, compliant labelling and a clear patient information leaflet.
- Warn patients about importation risks, counterfeits and the lack of regulation with many Sildalis vendors and recommend local prescriber or pharmacist alternatives.
Mechanism Of Action & Pharmacology
Both sildenafil and tadalafil are phosphodiesterase type 5 (PDE5) inhibitors that enhance nitric oxide–mediated vasodilation in penile tissue and improve erection quality with sexual stimulation.
Combining them targets the same biochemical pathway and there is no established data showing additional clinical benefit from routine combination use while it clearly raises adverse‑effect risk.
Simplified Explanation
- Nitric oxide release increases cyclic GMP levels.
- Increased cGMP causes smooth muscle relaxation in the corpus cavernosum.
- Relaxation increases penile blood flow leading to improved erection during sexual stimulation.
Clinical Terms
- Onset And Half‑Life
- Sildenafil has an onset around 30–60 minutes and a half‑life of approximately 4–5 hours, while tadalafil has a longer half‑life up to about 36 hours explaining its extended duration.
- CYP3A4 Metabolism
- Both agents are metabolised via CYP3A4, which explains interaction potential with protease inhibitors, some antifungals and macrolide antibiotics.
- Additive Hypotension
- Both drugs can lower blood pressure and using both increases the risk of clinically significant hypotension.
There are no formal pharmacokinetic studies for the fixed sildenafil+tadalafil combination registered in public regulatory literature.
Indications And Off‑Label Uses
Sildenafil and tadalafil individually are approved for erectile dysfunction by the TGA, and tadalafil also has licensed indications for benign prostatic hyperplasia and certain pulmonary arterial hypertension formulations.
Sildalis the combination is not TGA‑listed and therefore has no approved indication as a fixed combination product.
Approved Indications By TGA
| Indication | Licensed Agent |
|---|---|
| Erectile Dysfunction | Sildenafil, Tadalafil |
| Benign Prostatic Hyperplasia | Tadalafil (specific formulations) |
| Pulmonary Arterial Hypertension | Specific Sildenafil/Tadalafil Formulations (not Sildalis consumer packs) |
Off‑Label Uses In Australian Practice
- Clinicians may use tadalafil daily for lower urinary tract symptoms or ED as per evidence for single agents.
- Combining two full‑dose PDE5 inhibitors is not standard practice and is considered experimental without supporting RCT data.
- Risks such as additive hypotension, visual disturbances and muscle pain typically outweigh any unproven benefit.
Document an informed discussion if a patient intends to use Sildalis and recommend evidence‑based single‑agent alternatives where possible.
Key Clinical Findings & Evidence Gaps
High‑quality randomised controlled trials support the efficacy and safety of sildenafil and tadalafil individually for erectile dysfunction.
There is no authoritative regulatory record for a combined sildenafil/tadalafil product and no published combination RCTs or comprehensive PK interaction studies for Sildalis.
- Available Evidence: Robust RCTs for individual PDE5 inhibitors supporting efficacy in ED.
- Missing Evidence: Combination RCTs, long‑term safety data, formal pharmacokinetic interaction studies for the fixed combo.
Clinicians should advise against routine use of unregulated combination products until peer‑reviewed data demonstrate safety and benefit.
Consider reporting cases of adverse outcomes to the TGA and, where appropriate, publish anonymised case series in line with ethical standards to support signal detection.
Alternatives Matrix And Decision Checklist
| Product | Typical Dose | TGA Status | PBS Listing | Pros | Cons |
|---|---|---|---|---|---|
| Viagra® (sildenafil) | 25–100 mg As Needed | Registered | Variable | Faster Onset | Shorter Duration |
| Cialis® (tadalafil) | 2.5–20 mg Daily Or As Needed | Registered | Variable | Longer Duration, Daily Option | Possible Muscle/Back Pain |
| Levitra® (vardenafil) | 10–20 mg As Needed | Registered | Variable | Alternative PDE5 Option | Less Widely Used |
PBS‑Listed Alternatives Comparison
- Decision Checklist: Assess severity of ED, cardiovascular risk, comorbidities, drug interactions, patient preference for on‑demand versus daily dosing, and cost concerns.
- For cost‑sensitive patients, generic sildenafil brands are commonly available and may be PBS‑subsidised depending on indication and entitlements.
- Combination products like Sildalis are unproven and should not be preferred over licensed single agents.
Common Pharmacy Questions & Consumer FAQs
Patients frequently ask whether Sildalis is legal in Australia and whether it is stronger than Viagra or Cialis.
- Is Sildalis Legal In Australia? It is not registered as a combination with the TGA and is often supplied via import or unregulated online sellers.
- Is It Stronger Than Viagra/Cialis? There is no reliable evidence that the combination is clinically superior and it carries higher adverse‑effect risk.
- Can I Buy Without A Script? Some overseas online sellers may sell without prescription but importation risks and quality concerns apply.
Pharmacists should document recommendations, provide written interaction advice and offer safer licensed alternatives where possible.
Report any quality concerns or suspected adverse events to the TGA promptly.
Price & Access Comparison
| Source | Typical Price Range (AUD) | PBS Subsidy | Prescription Required |
|---|---|---|---|
| Chemist Warehouse (Generic Sildenafil) | Low (Varies By Pack Size) | Possible If Eligible | Yes |
| Priceline / TerryWhite | Moderate | Possible If Eligible | Yes |
| Overseas Online Sildalis | Variable, Often Low | None | Often No |
Access Checklist
- Use GP or accredited telehealth to obtain a lawful prescription for sildenafil or tadalafil.
- Choose accredited Australian online pharmacies for convenience and safety.
- Rural patients may use telehealth but ensure local pharmacist follow‑up and access to emergency care if needed.
- Check labelling, expiry and batch number and avoid suspiciously cheap imports.
Registration, Regulation And Reporting
Sildalis is not registered with major drug agencies as a fixed combination product and does not appear as an approved combination in public registries.
In Australia, sildenafil and tadalafil are prescription medicines regulated by the TGA and PBS listings depend on formulation and indication criteria.
TGA Approval
Check the Australian Register of Therapeutic Goods (ARTG) for the current status of any medicine before considering supply or recommending an imported product.
PBS Subsidy Details
PBS eligibility depends on clinical indication and prescriber authority and combination products without TGA approval are not PBS‑eligible.
- Pharmacist Checklist: Verify ARTG entry, confirm prescription authenticity, counsel on importation risks and report adverse events via the TGA online incident reporting system.
Storage, Handling And Supply Chain Considerations
Store PDE5 inhibitors below 30°C, away from moisture and direct sunlight and keep them out of reach of children.
Avoid leaving tablets in hot cars or exposed to high summer temperatures in Australian homes.
Household Storage In Australian Climate
- Use a cool, dry storage area at home away from bathrooms and kitchen steam.
- Avoid glovebox storage in hot months and consider insulated containers if travel is likely.
Cold‑Chain Handling For Pharmacies
Standard PDE5 inhibitors do not require refrigeration but pharmacies should monitor storage temperatures in delivery vehicles during hot weather and retain original packaging for traceability.
When patients obtain medicines from overseas, advise them to keep original packaging, batch numbers and supplier contact details and to be cautious of damaged or oddly labelled products.
Guidelines For Proper Use And Pharmacist Counselling Style
Use patient‑centred, non‑judgemental language when counselling about erectile dysfunction treatment options.
Document medical history, current medications and cardiovascular risk before recommending any PDE5 inhibitor.
Australian Pharmacist Counselling Checklist
- Confirm prescription legitimacy and identity of prescriber.
- Screen for nitrates or riociguat use and cardiovascular contraindications.
- Discuss common side effects and provide a written action plan for priapism and severe hypotension.
- Recommend switching to a single licensed agent with PBS support where appropriate.
- Document informed consent when a patient insists on using an unregulated product after counselling.
Patient Advice From PBS And National Health Authorities
Encourage follow‑up with the patient’s GP after starting therapy and consider alternatives such as sildenafil or tadalafil single agents that have clear dosing and subsidy rules.
Common Pharmacy Scripts And Practical Counselling Lines
“Tell me about every medicine you take, including nitrates, heart medicines and recreational drugs.”
“Do not take this product with nitroglycerin, and seek urgent care if you have severe chest pain or fainting.”
“If an erection lasts longer than four hours, go to the nearest emergency department immediately.”
“If you buy medicines online, keep photos of the packaging and batch number and bring them to the pharmacy if you experience problems.”
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Gold Coast | Queensland | 9-14 days |
| Newcastle | New South Wales | 9-14 days |
| Wollongong | New South Wales | 14-21 days |
| Townsville | Queensland | 14-21 days |
| Geelong | Victoria | 14-21 days |
| Ballarat | Victoria | 14-21 days |
| Cairns | Queensland | 14-21 days |
Final Safety Reminders And Next Steps
Do not supply or recommend Sildalis to anyone on nitrates or riociguat because of life‑threatening hypotension risks.
Prioritise a documented screening checklist covering cardiovascular history, current medications, vision problems and liver or kidney disease before any supply.
When patients report harm, collect dose, supplier, co‑meds and duration and forward adverse event reports to the TGA with packaging photos where possible.
Offer evidence‑based single‑agent alternatives such as sildenafil or tadalafil, discuss PBS options and refer to a GP or cardiologist if cardiovascular risk is identified.
Keep a clear, non‑judgemental counselling note and ensure the patient understands emergency signs requiring immediate care.